NEW YORK (GenomeWeb) – Dublin, Ireland-based HiberGene Diagnostics announced today the CE-IVD marking and launch of its first molecular assay, a test for bacterial meningitis.

Called HG Meningococcus, the test uses loop-mediated isothermal amplification to detect the DNA of all known pathogenic Neisseria meningitidis serogroups, and "meets a significant unmet clinical need using advanced and proven technology," HiberGene CEO Brendan Farrell said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.